SHA
AGN

Smith Hayes Advisers’s Allergan plc AGN Stock Holding History

Smith Hayes Advisers’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$973K Hold
3,630
– – 0.2% 135
2015
Q4 		$1.13M Sell
3,630
-645
-15% -$192K 0.24% 116
2015
Q3 		$1.16M Sell
4,275
-155
-3% -$47.6K 0.25% 112
2015
Q2 		$1.34M Buy
+4,430
New +$1.32M 0.27% 111

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Smith Hayes Advisers's AGN Position: Q1 2016 in Review

Smith Hayes Advisers held its Allergan plc (AGN) position steady in Q1 2016 at 3,630 shares worth $973K. The position accounts for 0.2% of the portfolio, ranked #135.

Smith Hayes Advisers first reported a position in AGN in Q2 2015 and has held it in 4 quarters since. The position peaked at $1.34M in Q2 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Smith Hayes Advisers held 3,630 shares of Allergan plc worth $973K as of Q1 2016.
  • Smith Hayes Advisers left its Allergan plc share count unchanged in Q1 2016.
  • Allergan plc made up 0.2% of Smith Hayes Advisers's portfolio in Q1 2016, its #135 holding.
  • Smith Hayes Advisers first reported a position in Allergan plc in Q2 2015 and has held it in 4 quarters since.
  • Smith Hayes Advisers's Allergan plc position peaked at $1.34M in Q2 2015.
  • 1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.